ClinicalTrials.Veeva

Menu

Evaluation of the Performance and Safety of Two Intradermal Delivery Devices.

PATH logo

PATH

Status

Completed

Conditions

Injections, Intradermal

Treatments

Device: ID adapter (autodisable)
Device: ID adapter (side load)

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to evaluate whether two intradermal (ID) vaccine delivery devices can safely and precisely inject liquid into the intradermal layer of the skin in three different injection locations

Full description

This study is a preliminary device safety and performance evaluation in healthy adult volunteers (ages 18-55 years).

Each participant will receive six injections of 0.1 ml of sterile saline solution into the skin:

  • Upper deltoid with the side-load ID adapter
  • Upper deltoid with the autodisable (AD) ID adapter
  • Suprascapular (behind the shoulder) with the side-load ID adapter
  • Suprascapular with the AD ID adapter
  • Forearm with the side-load ID adapter
  • Forearm with the AD ID adapter

Intradermal administration of each injection will be assessed:

  • The liquid remaining on the surface of the skin will be blotted with absorbent paper and the amount of liquid present will be recorded.
  • The formation of an intradermal wheal will be observed, and the diameter of the wheal measured using a ruler or similar measurement tool.
  • A photo of the injection site will be taken.

Injections will be assessed for safety by observation of injection sites for any local adverse events.

Enrollment

30 patients

Sex

All

Ages

18 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Female and male participants ages 18 to 55 years.
  • Healthy enough to participate in the clinical trial per site investigator assessment.
  • Healthy skin on the upper deltoid, suprascapular, and forearm regions (both sides of the body).
  • Able to provide signed informed consent and understand study procedures per ICH/GCP guidelines.
  • Literate in English.
  • Available by telephone 48 hours after the study visit.

Exclusion criteria

  • Skin abnormalities on upper deltoid, suprascapular, and forearm regions of either side of the body (scars, rash, infection), tattoo at the injection site, or other skin conditions that would interfere with the ability to visualize an intradermal injection in the opinion of the investigator.

Trial design

Primary purpose

Prevention

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

Saline injection with ID adapters
Experimental group
Description:
Each participant will receive six injections of 0.1 ml of sterile saline solution into the skin: * Upper deltoid with the side-load ID adapter * Upper deltoid with the AD ID adapter * Suprascapular (behind the shoulder) with the side-load ID adapter * Suprascapular with the AD ID adapter * Forearm with the side-load ID adapter * Forearm with the AD ID adapter
Treatment:
Device: ID adapter (side load)
Device: ID adapter (autodisable)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems